help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kieffer, T. J.
Right arrow Articles by Francis Habener, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kieffer, T. J.
Right arrow Articles by Francis Habener, J.
Endocrine Reviews 20 (6): 876-913
Copyright © 1999 by The Endocrine Society

The Glucagon-Like Peptides

Timothy James Kieffer1 and Joel Francis Habener2

Departments of Medicine and Physiology (T.J.K.), University of Alberta, Edmonton, Alberta, Canada T6G 2S2; and Laboratory of Molecular Endocrinology (J.F.H.), Massachusetts General Hospital, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02114

I. Introduction
II. History of the Incretin Concept: Discovery of Gastric Inhibitory Polypeptide
III. Discovery of GLP-1
IV. Structures of GLPs and Family of Glucagon-Related Peptides
V. Tissue Distribution of the Expression of GLPs
A. Pancreatic {alpha}-cells
B. Intestinal L cells
C. Central nervous system
VI. Proglucagon Biosynthesis
A. Organization/structure of the proglucagon gene
B. Regulation of glucagon gene expression
C. Posttranslational processing of proglucagon
VII. Regulation of GLP Secretion
A. Overview
B. Intracellular signals
C. Carbohydrates
D. Fats
E. Proteins
F. Endocrine
G. Neural
H. GLP-2
VIII. Metabolism of GLPs
A. GLP-1
B. GLP-2
IX. Physiological Actions of GLPs
A. Overview
B. Pancreatic islets
C. Counterregulatory actions of GLP-1 and leptin on ß-cells
D. Stomach
E. Lung
F. Brain
G. Liver, skeletal muscle, and fat
H. Pituitary, hypothalamus, and thyroid
I. Cardiovascular system
J. GLP-2
X. GLP Receptors
A. Structure
B. Signaling
C. Distribution
D. Regulation
E. GLP-2
XI. Pathophysiology of GLP-1
XII. GLP-1 as a Potential Treatment for Diabetes Mellitus

XIII. Future Directions




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
J. Vrbikova, M. Hill, B. Bendlova, T. Grimmichova, K. Dvorakova, K. Vondra, and G. Pacini
Incretin levels in polycystic ovary syndrome
Eur. J. Endocrinol., August 1, 2008; 159(2): 121 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Salehi, B. A. Aulinger, and D. A. D'Alessio
Targeting {beta}-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins
Endocr. Rev., May 1, 2008; 29(3): 367 - 379.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
D. F. Kruger
Exploring the Pharmacotherapeutic Options for Treating Type 2 Diabetes
The Diabetes Educator, May 1, 2008; 34(Supplement_3): 60S - 65S.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B.-J. Kim, K.-H. Park, C.-Y. Yim, S. Takasawa, H. Okamoto, M.-J. Im, and U.-H. Kim
Generation of Nicotinic Acid Adenine Dinucleotide Phosphate and Cyclic ADP-Ribose by Glucagon-Like Peptide-1 Evokes Ca2+ Signal That Is Essential for Insulin Secretion in Mouse Pancreatic Islets
Diabetes, April 1, 2008; 57(4): 868 - 878.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Liu and J. F. Habener
Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation
J. Biol. Chem., March 28, 2008; 283(13): 8723 - 8735.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Huo, K. M. Gamber, H. J. Grill, and C. Bjorbaek
Divergent Leptin Signaling in Proglucagon Neurons of the Nucleus of the Solitary Tract in Mice and Rats
Endocrinology, February 1, 2008; 149(2): 492 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
G. G. Holz, E. Heart, and C. A. Leech
Synchronizing Ca2+ and cAMP oscillations in pancreatic {beta}-cells: a role for glucose metabolism and GLP-1 receptors?Focus on "Regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic {beta}-cell: a computational approach"
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C4 - C6.
[Full Text] [PDF]

Home page
 J Clin PharmacolHome page
Y.-L. He, M. Ligueros-Saylan, G. Sunkara, R. Sabo, C. Zhao, Y. Wang, J. Campestrini, F. Pommier, K. Dole, A. Marion, et al.
Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects
J. Clin. Pharmacol., January 1, 2008; 48(1): 85 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. D'Alessio, W. Lu, W. Sun, S. Zheng, Q. Yang, R. Seeley, S. C. Woods, and P. Tso
Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2163 - R2169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso
The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G963 - G971.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. D. Wideman, S. D. Covey, G. C. Webb, D. J. Drucker, and T. J. Kieffer
A Switch From Prohormone Convertase (PC)-2 to PC1/3 Expression in Transplanted {alpha}-Cells Is Accompanied by Differential Processing of Proglucagon and Improved Glucose Homeostasis in Mice
Diabetes, November 1, 2007; 56(11): 2744 - 2752.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev, October 1, 2007; 87(4): 1409 - 1439.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. P. Vahl, M. Tauchi, T. S. Durler, E. E. Elfers, T. M. Fernandes, R. D. Bitner, K. S. Ellis, S. C. Woods, R. J. Seeley, J. P. Herman, et al.
Glucagon-Like Peptide-1 (GLP-1) Receptors Expressed on Nerve Terminals in the Portal Vein Mediate the Effects of Endogenous GLP-1 on Glucose Tolerance in Rats
Endocrinology, October 1, 2007; 148(10): 4965 - 4973.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
G. Sunkara, R. Sabo, Y. Wang, Y.-L. He, J. Campestrini, M. Rosenberg, D. Howard, and W. P. Dole
Dose Proportionality and the Effect of Food on Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, in Healthy Volunteers
J. Clin. Pharmacol., September 1, 2007; 47(9): 1152 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y.-S. Lee, S. Shin, T. Shigihara, E. Hahm, M.-J. Liu, J. Han, J.-W. Yoon, and H.-S. Jun
Glucagon-Like Peptide-1 Gene Therapy in Obese Diabetic Mice Results in Long-Term Cure of Diabetes by Improving Insulin Sensitivity and Reducing Hepatic Gluconeogenesis
Diabetes, June 1, 2007; 56(6): 1671 - 1679.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Korner, M. Stockli, B. Waser, and J. C. Reubi
GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
J. Nucl. Med., May 1, 2007; 48(5): 736 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. E. Dunning and J. E. Gerich
The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications
Endocr. Rev., May 1, 2007; 28(3): 253 - 283.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X.-Y. Chu, K. Bleasby, J. Yabut, X. Cai, G. H. Chan, M. J. Hafey, S. Xu, A. J. Bergman, M. P. Braun, D. C. Dean, et al.
Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 673 - 683.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. H. Vincent, J. R. Reed, A. J. Bergman, C. S. Elmore, B. Zhu, S. Xu, D. Ebel, P. Larson, W. Zeng, L. Chen, et al.
Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in Humans
Drug Metab. Dispos., April 1, 2007; 35(4): 533 - 538.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. L. Kien, R. Blauwiekel, J. Y. Bunn, T. L. Jetton, W. L. Frankel, and J. J. Holst
Cecal Infusion of Butyrate Increases Intestinal Cell Proliferation in Piglets
J. Nutr., April 1, 2007; 137(4): 916 - 922.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
T. H Claus, C. Q Pan, J. M Buxton, L. Yang, J. C Reynolds, N. Barucci, M. Burns, A. A Ortiz, S. Roczniak, J. N Livingston, et al.
Dual-acting peptide with prolonged glucagon-like peptide-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes
J. Endocrinol., February 1, 2007; 192(2): 371 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. B. Knudsen, D. Kiel, M. Teng, C. Behrens, D. Bhumralkar, J. T. Kodra, J. J. Holst, C. B. Jeppesen, M. D. Johnson, J. C. de Jong, et al.
From the Cover: Small-molecule agonists for the glucagon-like peptide 1 receptor
PNAS, January 16, 2007; 104(3): 937 - 942.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R K. Campbell
Rationale for Dipeptidyl Peptidase 4 Inhibitors: A New Class of Oral Agents for the Treatment of Type 2 Diabetes Mellitus
Ann. Pharmacother., January 1, 2007; 41(1): 51 - 60.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. Wild, M. Behe, A. Wicki, D. Storch, B. Waser, M. Gotthardt, B. Keil, G. Christofori, J. C. Reubi, and H. R. Macke
[Lys40(Ahx-DTPA-111In)NH2]Exendin-4, a Very Promising Ligand for Glucagon-like Peptide-1 (GLP-1) Receptor Targeting
J. Nucl. Med., December 1, 2006; 47(12): 2025 - 2033.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Aschner, M. S. Kipnes, J. K. Lunceford, M. Sanchez, C. Mickel, D. E. Williams-Herman, and for the Sitagliptin Study 021 Group
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Diabetes Care, December 1, 2006; 29(12): 2632 - 2637.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Reimann, P. S. Ward, and F. M. Gribble
Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1
Diabetes, December 1, 2006; 55(Supplement_2): S78 - S85.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. A. Hussain, D. L. Porras, M. H. Rowe, J. R. West, W.-J. Song, W. E. Schreiber, and F. E. Wondisford
Increased Pancreatic {beta}-Cell Proliferation Mediated by CREB Binding Protein Gene Activation
Mol. Cell. Biol., October 15, 2006; 26(20): 7747 - 7759.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
R. A Reimer
Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases.
J. Endocrinol., October 1, 2006; 191(1): 159 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. D. Wideman, I. L. Y. Yu, T. D. Webber, C. B. Verchere, J. D. Johnson, A. T. Cheung, and T. J. Kieffer
Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)
PNAS, September 5, 2006; 103(36): 13468 - 13473.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. F. Luco, M. A. Maestro, N. del Pozo, W. M. Philbrick, P. P. de la Ossa, and J. Ferrer
A Conditional Model Reveals That Induction of Hepatocyte Nuclear Factor-1{alpha} in Hnf1{alpha}-Null Mutant {beta}-Cells Can Activate Silenced Genes Postnatally, Whereas Overexpression Is Deleterious.
Diabetes, August 1, 2006; 55(8): 2202 - 2211.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
G. A. Herman, A. Bergman, F. Liu, C. Stevens, A. Q. Wang, W. Zeng, L. Chen, K. Snyder, D. Hilliard, M. Tanen, et al.
Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP-4 Inhibitor Sitagliptin in Middle-Aged Obese Subjects.
J. Clin. Pharmacol., August 1, 2006; 46(8): 876 - 886.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. Zhao, P. Parikh, S. Bhashyam, H. Bolukoglu, I. Poornima, Y.-T. Shen, and R. P. Shannon
Direct Effects of Glucagon-Like Peptide-1 on Myocardial Contractility and Glucose Uptake in Normal and Postischemic Isolated Rat Hearts
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1106 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Wang, T. Liu, Z. Li, X. Ma, and T. Jin
Redundant and Synergistic Effect of Cdx-2 and Brn-4 on Regulating Proglucagon Gene Expression
Endocrinology, April 1, 2006; 147(4): 1950 - 1958.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Zhou, M. Nian, J. Gu, and D. M. Irwin
Intron 1 sequences are required for pancreatic expression of the human proglucagon gene
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R634 - R641.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. M. Gardiner, J. E. March, P. A. Kemp, and T. Bennett
Mesenteric Vasoconstriction and Hindquarters Vasodilatation Accompany the Pressor Actions of Exendin-4 in Conscious Rats
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 852 - 859.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Park, X. Dong, T. L. Fisher, S. Dunn, A. K. Omer, G. Weir, and M. F. White
Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic beta Cell Growth and Function
J. Biol. Chem., January 13, 2006; 281(2): 1159 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
D. D. De Leon, C. Farzad, M. F. Crutchlow, J. Brestelli, J. Tobias, K. H. Kaestner, and D. A. Stoffers
Identification of transcriptional targets during pancreatic growth after partial pancreatectomy and exendin-4 treatment
Physiol Genomics, January 12, 2006; 24(2): 133 - 143.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Gameiro, F. Reimann, A. M. Habib, D. O'Malley, L. Williams, A. K. Simpson, and F. M. Gribble
The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line
J. Physiol., December 15, 2005; 569(3): 761 - 772.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Dardevet, M. C. Moore, C. A. DiCostanzo, B. Farmer, D. W. Neal, W. Snead, M. Lautz, and A. D. Cherrington
Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors
Am J Physiol Gastrointest Liver Physiol, November 1, 2005; 289(5): G806 - G814.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. Seino and T. Shibasaki
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Physiol Rev, October 1, 2005; 85(4): 1303 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-J. Kim, W. S. Choi, J. S. M. Han, G. Warnock, D. Fedida, and C. H. S. McIntosh
A Novel Mechanism for the Suppression of a Voltage-gated Potassium Channel by Glucose-dependent Insulinotropic Polypeptide: PROTEIN KINASE A-DEPENDENT ENDOCYTOSIS
J. Biol. Chem., August 5, 2005; 280(31): 28692 - 28700.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C. W Hay, E. M Sinclair, G. Bermano, E. Durward, M. Tadayyon, and K. Docherty
Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site
J. Endocrinol., August 1, 2005; 186(2): 353 - 365.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. J. Meier, G. Kemmeries, J. J. Holst, and M. A. Nauck
Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects
Diabetes, July 1, 2005; 54(7): 2212 - 2218.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
G. Kang, O. G Chepurny, M. J Rindler, L. Collis, Z. Chepurny, W.-h. Li, M. Harbeck, M. W Roe, and G. G Holz
A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic {beta} cells
J. Physiol., July 1, 2005; 566(1): 173 - 188.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-J. Kim, K. Winter, C. Nian, M. Tsuneoka, Y. Koda, and C. H. S. McIntosh
Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic {beta}-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression
J. Biol. Chem., June 10, 2005; 280(23): 22297 - 22307.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Masur, E. C. Tibaduiza, C. Chen, B. Ligon, and M. Beinborn
Basal Receptor Activation by Locally Produced Glucagon-Like Peptide-1 Contributes to Maintaining {beta}-Cell Function
Mol. Endocrinol., May 1, 2005; 19(5): 1373 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 J HeredHome page
D. M. Irwin and K. Wong
Evolution of New Hormone Function: Loss and Gain of a Receptor
J. Hered., May 1, 2005; 96(3): 205 - 211.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
F Reimann, M Maziarz, G Flock, A. M Habib, D. J Drucker, and F. M Gribble
Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line
J. Physiol., February 15, 2005; 563(1): 161 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. A. Koehler, B. Yusta, and D. J. Drucker
The HeLa Cell Glucagon-Like Peptide-2 Receptor Is Coupled to Regulation of Apoptosis and ERK1/2 Activation through Divergent Signaling Pathways
Mol. Endocrinol., February 1, 2005; 19(2): 459 - 473.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Yi, P. L. Brubaker, and T. Jin
TCF-4 Mediates Cell Type-specific Regulation of Proglucagon Gene Expression by {beta}-Catenin and Glycogen Synthase Kinase-3{beta}
J. Biol. Chem., January 14, 2005; 280(2): 1457 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. J. Meier, B. Gallwitz, B. Kask, C. F. Deacon, J. J. Holst, W. E. Schmidt, and M. A. Nauck
Stimulation of Insulin Secretion by Intravenous Bolus Injection and Continuous Infusion of Gastric Inhibitory Polypeptide in Patients With Type 2 Diabetes and Healthy Control Subjects
Diabetes, December 1, 2004; 53(suppl_3): S220 - S224.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. Harder, L. Nielsen, T. D.T. Thi, and A. Astrup
The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes
Diabetes Care, August 1, 2004; 27(8): 1915 - 1921.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. K. C. Chow, T. W. Moon, R. L. C. Hoo, C.-M. Yeung, M. Muller, P. J. Christos, and S. Mojsov
Identification and Characterization of a Glucagon Receptor from the Goldfish Carassius auratus: Implications for the Evolution of the Ligand Specificity of Glucagon Receptors in Vertebrates
Endocrinology, July 1, 2004; 145(7): 3273 - 3288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. Dardevet, M. C. Moore, D. Neal, C. A. DiCostanzo, W. Snead, and A. D. Cherrington
Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E75 - E81.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. F. List and J. F. Habener
Glucagon-like peptide 1 agonists and the development and growth of pancreatic {beta}-cells
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E875 - E881.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
D. A. D'Alessio and T. P. Vahl
Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes
Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Tomimoto, H. Hashimoto, N. Shintani, K. Yamamoto, Y. Kawabata, K.-I. Hamagami, K. Yamagata, J.-I. Miyagawa, and A. Baba
Overexpression of Pituitary Adenylate Cyclase-Activating Polypeptide in Islets Inhibits Hyperinsulinemia and Islet Hyperplasia in Agouti Yellow Mice
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 796 - 803.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. P. Goldstone, E. L. Thomas, A. E. Brynes, G. Castroman, R. Edwards, M. A. Ghatei, G. Frost, A. J. Holland, A. B. Grossman, M. Korbonits, et al.
Elevated Fasting Plasma Ghrelin in Prader-Willi Syndrome Adults Is Not Solely Explained by Their Reduced Visceral Adiposity and Insulin Resistance
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1718 - 1726.
[Abstract] [Full Text] [PDF]